Dr. William Aronson, MD

NPI: 1639194095
Total Payments
$753,306
2024 Payments
$83,655
Companies
25
Transactions
737

Payment Breakdown by Category

Other$579,585 (76.9%)
Travel$102,820 (13.6%)
Consulting$58,827 (7.8%)
Food & Beverage$12,065 (1.6%)
Education$8.54 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $573,610 186 76.1%
Travel and Lodging $102,820 293 13.6%
Consulting Fee $58,827 20 7.8%
Food and Beverage $12,065 234 1.6%
Honoraria $5,975 3 0.8%
Education $8.54 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $259,851 201 $0 (2024)
PFIZER INC. $129,477 115 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $125,972 109 $0 (2024)
Janssen Scientific Affairs, LLC $106,938 110 $0 (2024)
Janssen Biotech, Inc. $71,347 97 $0 (2024)
AstraZeneca Pharmaceuticals LP $10,508 11 $0 (2024)
Ferring Pharmaceuticals Inc. $9,727 16 $0 (2024)
Amgen Inc. $9,672 8 $0 (2021)
Sumitomo Pharma America, Inc. $6,754 2 $0 (2024)
Blue Earth Diagnostics Limited $6,212 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $83,655 98 Astellas Pharma US Inc ($37,306)
2023 $83,667 85 Astellas Pharma US Inc ($27,362)
2022 $68,729 69 Bayer HealthCare Pharmaceuticals Inc. ($41,260)
2021 $55,624 41 Astellas Pharma US Inc ($14,758)
2020 $71,007 58 Bayer HealthCare Pharmaceuticals Inc. ($24,175)
2019 $94,881 91 PFIZER INC. ($44,446)
2018 $167,695 173 Janssen Scientific Affairs, LLC ($67,390)
2017 $128,047 122 Astellas Pharma US Inc ($68,577)

All Payment Transactions

737 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Consulting Fee Cash or cash equivalent $2,300.00 General
Category: Oncology
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Travel and Lodging Cash or cash equivalent $80.00 General
Category: Oncology
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Travel and Lodging Cash or cash equivalent $59.60 General
Category: Oncology
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage Cash or cash equivalent $25.73 General
Category: Oncology
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage Cash or cash equivalent $12.83 General
Category: Oncology
12/19/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage Cash or cash equivalent $8.71 General
Category: Oncology
12/05/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Travel and Lodging In-kind items and services $294.06 General
Category: Oncology
12/04/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Consulting Fee Cash or cash equivalent $6,980.00 General
Category: Oncology
12/04/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Travel and Lodging In-kind items and services $391.76 General
Category: Oncology
12/04/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Travel and Lodging In-kind items and services $224.48 General
Category: Oncology
12/04/2024 Janssen Scientific Affairs, LLC ERLEADA (Drug) Food and Beverage In-kind items and services $149.12 General
Category: Oncology
12/04/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $77.75 General
Category: Oncology
12/04/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $30.19 General
Category: Oncology
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Travel and Lodging In-kind items and services $209.10 General
Category: Oncology
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $66.76 General
Category: Oncology
12/03/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Travel and Lodging In-kind items and services $61.99 General
Category: Oncology
11/16/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $8,453.00 General
Category: Oncology
11/16/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Travel and Lodging In-kind items and services $141.92 General
Category: Oncology
11/16/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $91.74 General
Category: Oncology
11/16/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $13.60 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
11/07/2024 Ferring Pharmaceuticals Inc. ADSTILADRIN (Biological) Food and Beverage In-kind items and services $27.15 General
Category: ONCOLOGY
11/01/2024 Janssen Biotech, Inc. ERLEADA (Drug), AKEEGA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $550.00 General
Category: Oncology
10/31/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $39.89 General
Category: Oncology
10/28/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug), Xofigo Food and Beverage In-kind items and services $99.77 General
Category: Oncology
10/25/2024 Boston Scientific Corporation AMS 700 (Device) Food and Beverage In-kind items and services $41.82 General
Category: AMS 700_URO

About Dr. William Aronson, MD

Dr. William Aronson, MD is a Urology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1639194095.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Aronson, MD has received a total of $753,306 in payments from pharmaceutical and medical device companies, with $83,655 received in 2024. These payments were reported across 737 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($573,610).

Practice Information

  • Specialty Urology
  • Location Los Angeles, CA
  • Active Since 07/13/2006
  • Last Updated 08/27/2008
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1639194095

Products in Payments

  • XTANDI (Drug) $209,631
  • Xtandi (Drug) $118,770
  • Nubeqa (Drug) $117,229
  • Erleada (Drug) $78,765
  • ERLEADA (Drug) $57,780
  • DARZALEX (Biological) $36,226
  • ORGOVYX (Drug) $14,895
  • LYNPARZA (Drug) $10,508
  • NOCDURNA (Drug) $9,202
  • Non-Covered (Drug) $6,921
  • Prolia (Biological) $5,039
  • XGEVA (Biological) $4,633
  • POSLUMA (Drug) $4,447
  • PYLARIFY (Drug) $2,600
  • Xofigo (Drug) $1,726
  • ELIGARD (Drug) $1,300
  • NO PRODUCT DISCUSSED (Drug) $883.16
  • PROVENGE (Drug) $726.86
  • FIRMAGON (Drug) $497.32
  • AQUABEAM ROBOTIC SYSTEM (Device) $205.42

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Los Angeles